Altogether, these data suggest that adiponectin may mediate its effects via obesity-independent mechanisms, but whether obesity per se or other pathways play a regulatory role is unclear and deserves further evaluation. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.